The restrictions on face-to-face care for exposure to biological material during the COVID-19 pandemic required alternatives to maintain outpatient assistance. This study evaluated the impact of telemedicine on care and outcome indicators of a reference service for exposure to biological material during the COVID-19 pandemic.
Methods:
This pre- and post-study compared the effectiveness of telemedicine in the Hospital Correia Picanço in Recife (Pernambuco, Brazil) before (August 2018 to January 2019 [P1]) and during the COVID-19 pandemic (August 2020 to January 2021 [P2]). Individuals above 18 years old exposed to biological material who sought the service during P1 or P2 were included in the study.
Results:
A total of 4,494 cases were assessed (1,997 in P1 and 2,497 in P2), mostly because of sexual exposure (62.3%). The mean age was 32.2 ± 9.2 years, most individuals were male (64.9%), originated from Recife (56.6%), and the education level was up to 12 years (53.7%). P2 presented 43% more attendances and shorter intervals between the exposure and first attendance (51%), first testing (28%), and discharge (10%) than P1 (p < 0.05), and cases had no difference in discharge rate (p = 0.339). Cases of sexual exposure had the highest dropout rate in both periods.
Conclusion:
Telemedicine maintained similar outcomes to face-to-face care and improved the indicators, increasing the mean monthly attendance and reducing the time between exposure and follow-up.
Get full access to this article
View all access options for this article.
References
1.
United Nations. Transformando nosso mundo: A agenda 2030 para o desenvolvimento sustentável, departamento de assuntos econômicos e sociais (transforming our world: The 2030 agenda for sustainable development, department of economic and social affairs); 2015. Available from: https://sdgs.un.org/2030agenda [Last accessed: August, 9].
RappariniC, SudoEC, SantosVGV, et al. (1a eds). Manual de condutas—exposição ocupacional a material biológico: Hepatite e HIV (conduct manual—occupational exposure to biological material: hepatitis and HIV). Ministério da Saúde: Brasília; 1999. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/manual_condutas_hepatite_hiv.pdf
Ministério da Saúde do Brasil. (1 eds). Protocolo clínico e diretrizes terapêuticas para profilaxia antirretroviral pós-exposição de risco à infecção pelo hiv (clinical protocol and therapeutic guidelines for post-exposure antiretroviral prophylaxis of risk for hiv infection). Ministério da Saúde: Brasília; 2015. Available from: https://docs.bvsalud.org/biblioref/2017/11/874905/relatorio_pcdt_pep_hiv__168_2015final.pdf
Organização Pan-Americana da Saúde. OMS afirma que COVID-19 é agora caracterizada como pandemia (Pan American Health Organization. WHO says COVID-19 is now characterized as a pandemic); 2020. Available from: https://www.paho.org/pt/news/11-3-2020-who-characterizes-covid-19-pandemic [Last accessed: February20, 2021].
Pernambuco Health Department. Portaria SES no 107/2020, 24 de Março de 2020 (Ordinance SES no 107/2020, march 24, 2020); 2020. Available from: https://www.legisweb.com.br/legislacao/?id=391518 [Last accessed: August15, 2021].
14.
Pernambuco Health Department. Portaria SES no 208/2020, 08 de Julho de 2020 (Ordinance SES no 208/2020, july 08, 2020); 2020. Available from: https://www.legisweb.com.br/legislacao/?id=396696 [Last accessed: August15, 2021].
15.
ShigemuraJ, UrsanoRJ, MorgansteinJC, et al.Respostas públicas ao novo coronavírus de 2019 (2019-nCoV) no Japão: Consequências para a saúde mental e populações-alvo [Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: Mental health consequences and target populations]. Psychiatry Clin Neurosci, 2020; 74(4):281–282; doi: 10.1111/pcn.12988
16.
RiesE. (1a eds). A Startup Enxuta: Como os empreendedores de hoje usam a inovação contínua para criar negócios radicalmente bem-sucedidos (The Lean Startup: How Today’s Entrepreneurs Use Continuous Innovation to Create Radically Successful Businesses). Currency; 2011.
17.
GuimarãesAC, BussolaRC, SilvaSEP. Comparação entre os métodos de “Processo de desenvolvimento de produto” e “Produto mínimo viável” (Comparison between the “Product Development Process” and “Minimum Viable Product” methods). In: Gestão Da Produção Em Foco: Belo Horizonte; 2021; pp. 54-62.
18.
Instituto Brasileiro de Geografia e Estatística. Censo Demográfico (Demographic Census); 2022. Available from: https://cidades.ibge.gov.br/brasil/pe/panorama [Last accessed: December1, 2023].
CarneiroMBG, EliasDBD. Análise da profilaxia pós-exposição ao HIV em um hospital de doenças infecciosas em Fortaleza, CE (HIV post-exposure prophylaxis in a hospital of infectious diseases in Fortaleza, CE). Rev Bras Anal Clin, 2018; 50(1):65–70; doi: 10.21877/2448-3877.201800631
22.
AndradeACC. Fatores sociodemográficos e clínicos relacionados a adesão e acompanhamento do uso da profilaxia pós- exposição sexual para o HIV (Sociodemographic and clinical factors related to adherence and monitoring the use of post-sexual exposure prophylaxis for HIV); 2018. Available from: https://repositorio.ufpb.br/jspui/handle/123456789/12305 [Last accessed: September6, 2021].
23.
LizaPH. Profilaxia pós-exposição sexual para HIV: Uma análise retrospectiva sobre a adesão e o seguimento das pessoas assistidas (Post-sexual exposure prophylaxis for HIV: A retrospective analysis of adherence and follow-up of people assisted). Available from: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1007621 [Last accessed: July26, 2021].
24.
OrlandiV, FronzaD, HorvathJAD, et al.Perfil clínico e epidemiológico de pacientes que buscam profilaxia pós-exposição sexual ao HIV e sua adesão à medicação em Cascavel, Paraná, Brasil (Clinical and epidemiological profile of patients who seek post-exposure prophylaxis after sexual exposure to HIV and their adherence to the medication regimen in a specialized center in Cascavel, Paraná, Brasil). DST–J Bras Doenças Sex Transm, 2019; 31(1):14–18; doi: 10.5533/DST-2177-8264-201931103
25.
AndradeWL. Fatores sociodemográficos e clínicos relacionados à adesão e ao acompanhamento ao uso da profilaxia pós-exposição para o HIV por acidente ocupacional (Sociodemographic and clinical factors related to adherence and monitoring the use of post-exposure prophylaxis for HIV due to occupational accidents); 2018. Available from: https://repositorio.ufpb.br/jspui/bitstream/123456789/16857/1/Arquivototal.pdf [Last accessed: September6, 2021].
26.
KonNM, SoltoskiF, RequeM, et al.Acidentes de trabalho com exposição a material biológico por Unidade Sentinela de Saúde do Trabalhador: 2.683 casos (Occupational accidents involving exposure to biological material by a Worker’s Health Sentinel Unit: 2,683 cases). Rev Bras Med Trab, 2011; 9(1):33–38.
27.
MizogutiNN, HirotaMM, ItoFY, et al.Acidentes de trabalho com exposição a material biológico notificados em unidade sentinela de saúde do trabalhador: 11.645 casos (Occupational accidents involving exposure to biological material reported at a Worker’s Health Sentinel Unit: 11,645 cases). Rev Bras Med Trab, 2022; 20(3):362–368; doi: 10.47626/1679-4435-2022-699
28.
PratesMVC, FigueiredoGM. Profilaxia pós-exposição (PEP) de risco à infecção pelo vírus da imunodeficiência humana (HIV) em tempos de Covid-19: Um estudo comparativo (Post-exposure prophylaxis (PEP) against the risk of human immunodeficiency virus (HIV) infection in times of Covid-19: A comparative study). Braz J Infect Dis, 2022; 26(1):102149; doi: 10.1016/j.bjid.2021.102149
JunejoM, GiromettiN, McOwanA, et al.Profilaxia pós-exposição ao HIV durante COVID-19 (HIV postexposure prophylaxis during COVID-19). Lancet HIV, 2020; 7(7):e460; doi: 10.1016/S2352-3018(20)30146-6
